Mural Oncology

3.73
-0.10 (-2.61%)
At close: Jan 29, 2025, 3:59 PM
3.72
-0.27%
After-hours Jan 29, 2025, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21
Revenue n/a n/a n/a
Cost of Revenue 2.57M 1.54M 1.47M
Gross Profit -2.57M -1.54M -1.47M
Operating Income -194.64M -195.15M -175.37M
Interest Income n/a n/a n/a
Pretax Income -195.29M -195.15M -175.37M
Net Income -207.45M -200.03M -175.43M
Selling & General & Admin 30.04M 25.08M 15.55M
Research & Development 162.03M 170.07M 159.82M
Other Expenses n/a n/a n/a
Operating Expenses 192.07M 195.15M 175.37M
Interest Expense n/a n/a n/a
Selling & Marketing Expenses -667.00K n/a n/a
Cost & Expenses 194.64M 195.15M 175.37M
Income Tax 12.16M 4.88M 68.00K
Shares Outstanding (Basic) 16.69M 16.69M 16.69M
Shares Outstanding (Diluted) 16.69M 16.69M 16.69M
EPS (Basic) -12.43 -11.99 -10.51
EPS (Diluted) -12.43 -11.99 -10.51
EBITDA -192.72M -183.38M -173.89M
Depreciation & Amortization 2.57M 1.54M 1.47M